Bob Mirzai

Bob Mirzai serves as an Adjunct Research Fellow at The University of Western Australia's UWA Medical School within the Pathology & Laboratory Medicine department. His research primarily focuses on hematological malignancies and diagnostic pathology, with significant contributions to understanding myeloproliferative neoplasms and bone marrow disorders.

His research interests span Hematology, Oncology, and Genomics, with particular expertise in myeloproliferative neoplasms, megakaryocyte biology, and bone marrow pathology. His work integrates molecular techniques including whole genome sequencing and novel biomarker discovery approaches to advance diagnostic methodologies in blood disorders.

Analysis of recent publications reveals a strong emphasis on translational research connecting basic science with clinical applications. His work demonstrates consistent focus on myeloproliferative disorders, with increasing incorporation of bioinformatics and digital pathology techniques in recent years. Key themes include megakaryocyte dysregulation in myelofibrosis, platelet biomarker discovery, and automated analysis of bone marrow specimens.

Mirzai actively collaborates with multidisciplinary research teams across hematology and pathology, evidenced by co-authorship on publications spanning multiple institutions. His research contributes to UN Sustainable Development Goals related to good health and well-being through advancements in cancer diagnostics and treatment monitoring.